Status:
COMPLETED
Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study
Lead Sponsor:
Benha University
Conditions:
Verruca Vulgaris
Involucrin
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Vitamin D3 plays important role in keratinocyte differentiation and had been used recently in verruca vulgaris. Aim of the work: To assess the expression of involucrin in verrucae vulgaris before and ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with multiple verruca vulgaris Patients with with verrucae vulgaris with size more than 3 cm
- Exclusion Criteria:
- Patients with a past history of allergic response to vitamin D. Pregnant or lactating females. Hepatic patients. Renal patients. Patients with bleeding tendency.
Exclusion
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04793529
Start Date
January 1 2019
End Date
October 1 2019
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Essam Mohamed El-sayed Akl
Banhā, Egypt